Login / Signup
Elif Baris
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Cancer Therapy
Signaling Pathway
Top Venues
Molecular biology reports
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ayse Banu Demir
,
Elif Baris
,
Umay Bengi Kaner
,
Hani Alotaibi
,
Neşe Atabey
,
Ahmet Koc
Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.
Molecular biology reports
(2023)